ONO PHARMACEUTICAL CO
π―π΅Japan
- Country
- π―π΅Japan
- Ownership
- -
- Established
- 1947-01-01
- Employees
- -
- Market Cap
- $7.1B
- Website
- https://www.ono.co.jp/
Study of Sivelestat Sodium Hydrate in Acute Lung Injury (ALI) Associated With Systemic Inflammatory Response Syndrome (SIRS) in Japan
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2005-09-22
- Last Posted Date
- 2015-04-23
- Lead Sponsor
- Ono Pharmaceutical Co. Ltd
- Target Recruit Count
- 649
- Registration Number
- NCT00219375
- Locations
- π―π΅
Kyushu Region Facility, Kyushu, Japan
π―π΅Tohoku Region Facility, Tohoku, Japan
π―π΅Kinki Region Facility, Kinki, Japan
ONO-7436 Phase II Study in Japan
Phase 2
Completed
- Conditions
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2012-06-14
- Lead Sponsor
- Ono Pharmaceutical Co. Ltd
- Target Recruit Count
- 420
- Registration Number
- NCT00212602
- Locations
- π―π΅
Chubu Region Facility, Chubu, Japan
π―π΅Hokkaido Region Facility, Hokkaido, Japan
π―π΅Shikoku Region Facility, Shikoku, Japan
Controlled Study of ONO-5920 in Patients With Involutional Osteoporosis in Japan
Phase 3
Completed
- Conditions
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2012-06-14
- Lead Sponsor
- Ono Pharmaceutical Co. Ltd
- Target Recruit Count
- 444
- Registration Number
- NCT00212628
- Locations
- π―π΅
Chubu Region Facility, Chubu, Japan
π―π΅Chugoku Region Facility, Chugoku, Japan
π―π΅Kanto Region Facility, Kanto, Japan
Controlled Study of ONO-8025 (KRP-197) in Patients With Overactive Bladder in Japan
Phase 2
Completed
- Conditions
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2012-10-12
- Lead Sponsor
- Ono Pharmaceutical Co. Ltd
- Target Recruit Count
- 400
- Registration Number
- NCT00212706
Controlled Study of ONO-5920 in Patients With Involutional Osteoporosis in Japan
Phase 3
Completed
- Conditions
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2012-10-11
- Lead Sponsor
- Ono Pharmaceutical Co. Ltd
- Target Recruit Count
- 650
- Registration Number
- NCT00212667
Controlled Study of ONO-5920 in Patients With Involutional Osteoporosis in Japan
Phase 3
Completed
- Conditions
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2012-10-11
- Lead Sponsor
- Ono Pharmaceutical Co. Ltd
- Target Recruit Count
- 250
- Registration Number
- NCT00212719
Controlled Study of ONO-2506PO in Patients With Parkinson's Disease in Japan
Phase 2
Completed
- Conditions
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2012-10-11
- Lead Sponsor
- Ono Pharmaceutical Co. Ltd
- Target Recruit Count
- 165
- Registration Number
- NCT00212693
Controlled Study of ONO-8025 (KRP-197) in Patients With Overactive Bladder in Japan
Phase 3
Completed
- Conditions
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2012-10-11
- Lead Sponsor
- Ono Pharmaceutical Co. Ltd
- Target Recruit Count
- 750
- Registration Number
- NCT00212732
Controlled Study of ONO-1101 in Patients With Postoperative Tachyarrhythmias in Japan
Phase 2
Completed
- Conditions
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2012-10-11
- Lead Sponsor
- Ono Pharmaceutical Co. Ltd
- Target Recruit Count
- 165
- Registration Number
- NCT00212654
Β© Copyright 2024. All Rights Reserved by MedPath